Identifying key bottlenecks in the early stages of antibiotic R&D and exploring public and not-for-profit solutions

  31 March 2023

A policy brief based on Expert workshop discussions organized under the ReAct initiative:
Revisiting Effective Models to Advance the Antibiotic Pipeline (REMAAP). 

Within the framework of this initiative ReAct organised an in-person workshop in Uppsala, Sweden on November 7-8th 2022. The workshop aimed to take an “end-to-end” approach to antibiotic R&D (from discovery to patient access), with specific attention given to the early stages (discovery and preclinical) of
antibiotic research and development. Discussions focussed on identifying the vulnerabilities, challenges, and potential solutions. The workshop gathered leading experts with knowledge particularly of the early stages of antibiotic R&D with backgrounds ranging from microbiology and chemistry, lab experience and compound development, infectious diseases and clinical medicine, economy, policy and history. This document synthesizes the identified challenges and suggests building blocks of more comprehensive solutions.

About REMAAP
The initiative ”Revisiting Effective Models to Advance the Antibiotic Pipeline”
(REMAAP) seeks to build evidence and broader political understanding of
the core challenges in antibiotic research and development and how to
effectively address them.

Further reading: ReAct
Author(s): ReAct
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed